Increase in Patient Contributions for Medications Due to Changes in GeSY Listings
February 18, 2026
Thousands of patients are facing significant increases in their contributions for certain medications due to changes in their categorization within the General Health System (GeSY). This change has been prompted by the expiration of drug patents, even though their prices have remained unchanged. Some medications used for the same condition contain different active ingredients. Patients have the option to switch to cheaper generic drugs, but the situation affects those who remain on the original medications. Agreements between the Health Insurance Organization and pharmaceutical companies influence the amount patients contribute.